RADCOM Ltd. (NASDAQ:RDCM – Get Free Report) saw a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 3,700 shares, a decline of 15.9% from the November 15th total of 4,400 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 54,300 shares, the short-interest ratio is presently 0.1 days.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered shares of RADCOM from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, December 4th.
View Our Latest Analysis on RDCM
Institutional Trading of RADCOM
RADCOM Stock Down 2.1 %
Shares of RDCM stock opened at $11.66 on Friday. The firm has a market cap of $182.60 million, a P/E ratio of 24.81 and a beta of 0.89. The company has a 50 day moving average of $11.13 and a 200-day moving average of $10.17. RADCOM has a 12-month low of $7.70 and a 12-month high of $12.84.
RADCOM Company Profile
RADCOM Ltd. provides 5G ready cloud-native, network intelligence, and service assurance solutions for telecom operators or communication service providers (CSPs). It offers RADCOM ACE, including RADCOM Service Assurance, a cloud-native, 5G-ready, and virtualized service assurance solutions, which allows telecom operators to gain end-to-end network visibility and customer experience insights across all networks; RADCOM Network Visibility, a cloud-native network packet broker and filtering solution that allows CSPs to manage network traffic at scale across multiple cloud environments, and control the visibility layer to perform analysis of select datasets; and RADCOM Network Insights, a business intelligence solution that offers insights for multiple use cases enabled by data captured and correlated through RADCOM Network Visibility and RADCOM Service Assurance.
See Also
- Five stocks we like better than RADCOM
- What is a Death Cross in Stocks?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Roth IRA Calculator: Calculate Your Potential Returns
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Pros And Cons Of Monthly Dividend Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for RADCOM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RADCOM and related companies with MarketBeat.com's FREE daily email newsletter.